Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

End-of-Life Care Patterns in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Real-World Setting

Paul A. Hamlin, Pallawi Torka, Eric Hansen, Andrew J. Belli, Jacob Ambrose, Christina M. Zettler, Laura L. Fernandes, Stephanie Wiley, Brittney Perry, Ching-Kun Wang

Blood (2024) 144 (Supplement 1): 3743.

https://doi.org/10.1182/blood-2024-203786

Published: 2024

Journal Articles

Impact of the Diagnosis-to-Treatment Interval (DTI) on Outcomes in Older Adults with Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Real-World Setting

Paul A. Hamlin, Pallawi Torka, Eric Hansen, Andrew J. Belli, Jacob Ambrose, Christina M. Zettler, Laura L. Fernandes, Stephanie Wiley, Brittney Perry, Ching-Kun Wang

Blood (2024) 144 (Supplement 1): 5101.

https://doi.org/10.1182/blood-2024-208852

Published: 2024

Journal Articles

Validation of a Composite Real-World Mortality Variable Among Patients with Hematologic Malignancies Treated in the United States

Sharlene Dong, Ankit J. Kansagra, Gurbakhash Kaur, Anna Barcellos, Andrew J. Belli, Laura L. Fernandes, Eric Hansen, Jacob Ambrose, Claire Bai, Christina M. Zettler, Ching-Kun Wang

Blood (2023) 142 (Supplement 1): 5145.

https://doi.org/10.1182/blood-2023-180263

Published: 2023

Journal Articles

Real-World Treatment Patterns and Outcomes of Patients (Pts) with Follicular Lymphoma (FL) Who Experienced Progression of Disease within 24 Months (POD24)

Muhammad Saad Hamid, Claire Bai, Chelsea Perelgut, Helena Yelovich, Christina M. Zettler, Laura L. Fernandes, Andrew J. Belli, Eric Hansen, Ching-Kun Wang

Blood (2023) 142 (Supplement 1): 3781.

https://doi.org/10.1182/blood-2023-182064

Published: 2023

Journal Articles

Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)

Rebecca Bystrom, Laura L. Fernandes, Joseph Wynne, Dianne Pulte, Eric Hansen, Andrew J. Belli, Anna Barcellos, Christina M. Zettler, Jonathon Vallejo, Kelly Norsworthy, Angelo De Claro, Catherine Lerro, Marc R Theoret, Ching-Kun Wang, Donna Rivera

Blood (2023) 142 (Supplement 1): 5189.

https://doi.org/10.1182/blood-2023-189060

Published: 2023

Journal Articles

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz

Blood (2022) 140 (Supplement 1): 7156–7157.

https://doi.org/10.1182/blood-2022-166842

Published: 2022

Journal Articles

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

William J Archibald, Anna Barcellos, Jacob Ambrose, Andrew J. Belli, Laura Fernandes, Eric Hansen, Ching-Kun Wang, Paul M. Barr

Blood (2022) 140 (Supplement 1): 4142–4143.

https://doi.org/10.1182/blood-2022-170596

Published: 2022

Journal Articles

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Dianne Pulte, Kelly J. Norsworthy, Laura Fernandes, Bindu Kanapuru, Catherine Lerro, Fatima Rizvi, Jonathon Vallejo, Kun Wang, Joseph Wynne, Anna Barcellos, Andrew J. Belli, Eric Hansen, Thomas Gwise, Paul Kluetz, Angelo De Claro, Ching-Kun Wang, Donna Rivera

Blood (2022) 140 (Supplement 1): 5100–5102.

https://doi.org/10.1182/blood-2022-169054

Published: 2022

Journal Articles

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Ben A Derman, Andrew J. Belli, Ching-Kun Wang, Eric Hansen, Spencer S Langerman, Andrzej Jakubowiak, Brian C-H Chiu

Blood (2021) 138 (Supplement 1): 3789.

https://doi.org/10.1182/blood-2021-149213

Published: 2021

Journal Articles

Identification of Barriers of CAR-T Utilization in Patients with Diffuse Large B-Cell Lymphoma

Farrukh T. Awan, Andrew J. Belli, Eric Hansen, Mimi Chung, Ching-Kun Wang

Blood (2021) 138 (Supplement 1): 1972.

https://doi.org/10.1182/blood-2021-153393

Published: 2021

Journal Articles

Frontline Venetoclax (ven) Based Combination Therapy in Older Adults with Acute Myeloid Leukemia Treated in the Real-World Setting; A Multi-Institutional Retrospective Study

Prapti A. Patel, Yazan F. Madanat, Andrew J. Belli, Eric Hansen, Heidi Foss, Molly Schulte, Ching-Kun Wang

Blood (2021) 138 (Supplement 1): 4136.

https://doi.org/10.1182/blood-2021-153186

Published: 2021

Journal Articles

Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data

Ankit Kansagra, Eric Hansen, Andrew J. Belli, Stefanie Goran, Ching-Kun Wang

Blood (2021) 138 (Supplement 1): 4093.

https://doi.org/10.1182/blood-2021-149724

Published: 2021

Journal Articles

Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma

Andrew J. Belli, MPH, Eric Hansen, MS, Ankit Kansagra, MD, Keshava Dilwali, MS, Ching-Kun Wang, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-142629

Published: 2020

Journal Articles

Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)

Andre Goy, MD, Tommy Wu, Eric Hansen, Srikesh Arunajadai, Ewelina Protomastro, MS, Marisa Valentinetti, BSN, RN, Maureen Murphy, BSN, RN, Judith E Smith, BSN, RN, Ruth Pe Benito, Ali Hasan, Kiran Suryadevara, Tatyana Feldman, MD, Alan P Skarbnik, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Michele L. Donato, MD, Andrew L. Pecora, MD, Stuart L. Goldberg, MD

Blood (2016) 128 (22): 2973.

https://doi.org/10.1182/blood.V128.22.2973.2973

Published: 2016

NARROW

End-of-Life Care Patterns in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Real-World Setting

Impact of the Diagnosis-to-Treatment Interval (DTI) on Outcomes in Older Adults with Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Real-World Setting

Validation of a Composite Real-World Mortality Variable Among Patients with Hematologic Malignancies Treated in the United States

Real-World Treatment Patterns and Outcomes of Patients (Pts) with Follicular Lymphoma (FL) Who Experienced Progression of Disease within 24 Months (POD24)

Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Real-World First-Line Treatment and Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Bruton Tyrosine Kinase Inhibitor (BTKi) or B-Cell Lymphoma 2 (BCL2) Therapy

Real-World Treatment Patterns Among Patients with Newly-Diagnosed (ND)-Acute Myeloid Leukemia (AML) in the United States (US)

Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

Identification of Barriers of CAR-T Utilization in Patients with Diffuse Large B-Cell Lymphoma

Frontline Venetoclax (ven) Based Combination Therapy in Older Adults with Acute Myeloid Leukemia Treated in the Real-World Setting; A Multi-Institutional Retrospective Study

Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data

Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma

Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only